User Manual
Table Of Contents
- Cover
- Table of Contents
- 1 Product Description
- 2 General Safety Instructions
- 3 Implantation
- Implantation Procedure
- Having parts ready
- Keeping an external defibrillator ready
- Unpacking the device
- Checking parts
- Implantation site
- Preventing leakage currents
- Preventing unintentional shock delivery
- Avoiding damage to the header
- Preventing short circuits in the header
- Ensure that connections are clean
- Connecting the lead connector to the device
- Keeping distance between leads
- Implanting
- Applying the programming head
- Establishing telemetry contact
- Activating ICD therapy
- Precautionary Measures while Programming
- Performing standard tests and monitoring the patient
- Cancelling telemetry
- Avoiding critical parameter settings
- Check for leads suitable for shock path
- Monitoring the patient when setting asynchronous modes
- Setting sensing
- Preventing device-induced complications
- Preventing conduction of atrial tachycardia
- Observing the shock impedance limit
- Preventing recurrence after therapy shock
- Phrenic nerve stimulation that cannot be terminated
- Avoiding risks in the case of exclusive LV pacing
- Recognizing lead failure
- Considering power consumption and service time
- Magnet Response
- Follow-up
- Patient Information
- Replacement Indications
- Explantation and Device Replacement
- Implantation Procedure
- 4 Parameters
- Bradycardia / CRT
- General ICD therapy
- Timing: Basic rate day/ night and rate hystereses
- Timing: AV delay
- Timing: Post-shock pacing
- Timing: Upper rate
- Timing: Mode switching
- Timing: Ventricular pacing
- Timing: Refractory periods and blanking periods
- Timing: PMT protection
- Timing: Rate adaptation via accelerometer
- Pacing: Pulse amplitude and pulse width
- Pacing: Ventricular capture control
- Pacing: atrial capture control
- LV lead configuration
- Tachycardia
- Sensing
- Diagnostics
- Home Monitoring
- Bradycardia / CRT
- 5 Technical Data
41 Technical Data
Resistance to interference • Note on device type DX (only devices with a DF-1/IS-1 connection): The EMC
requirements are met as long as atrial sensitivity is set to 1.0 mV (factory set-
tings) or values ≥ 1.0 mV. Measures must be taken to assure interference-free
therapy if more sensitive values are set.
• Note on device type HF: In the case of unipolar sensing, the requirement for
interference voltages of ≤ 0.3 mV (tip to tip) is met.
Common mode rejection
ATP amplitude A burst was measured at 500 Ω, an amplitude of 7.5 V (tolerance ±1.5 V), pulse
width of 1.5 ms, R-S1 interval of 300 ms and an S1 count of 5:
Automatic sensitivity
setting
Measurement of actual values and test signal wave shape: standard triangle. For
the device type DX, the programmed atrial sensitivity is intensified by a factor of 4.
Shock energy / peak voltage With shock path: RV to housing + SVC
Rate Common mode rejection ratio
Atrium: DX* Atrium: DR,
HF
V right: VR, DR,
HF
V left: HF
16.6 Hz 58 dB 53 dB 64 dB 66 dB
50 Hz 55 dB 55 dB 64 dB 66 dB
60 Hz 56 dB 56 dB 64 dB 68 dB
* only devices with a DF-1/IS-1 connection.
ATP amplitude Measured
minimum
Measured
maximum
Mean value
RV 7.67 V 7.67 V 5.00 V
LV 7.67 V 7.67 V 4.99 V
Sensitivity Value Tolerance Measured value
A: positive 0.2 mV 0.2 ... 0.5 0.24 mV
A: negative 0.24 mV
DX: A: positive 0.2 mV 0.2 ... 0.52
(0.05 to 0.13)
0.05 mV
DX:A:negative 0.05mV
RV: positive 0.5 mV 0.3 ... 0.7 0.48 mV
RV: negative 0.40 mV
LV: positive 0.5 mV 0.3 ... 0.7 0.48 mV
LV: negative 0.56 mV
Shock energy (Toler-
ance)
Tolerance peak
voltage
Measured
value
Shock energy
Measured
value
Peak voltage
1 J (0.7 ... 1.18) 90 ... 120 V 0.84 J 100 V
20 J (16.9 ... 20.9) 440 ... 480 V 18.1 J 469 V
40 J (33.8 ... 41.4) 620 ... 690 V 36.9 J 667 V